A detailed history of Israel Englander (Millennium Management LLC) transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 204,047 shares of LUCD stock, worth $204,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,047
Holding current value
$204,047
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.79 - $1.59 $161,197 - $324,434
204,047 New
204,047 $304,000
Q4 2022

Feb 14, 2023

SELL
$1.21 - $2.27 $7,988 - $14,986
-6,602 Reduced 27.04%
17,814 $24,000
Q3 2022

Nov 14, 2022

BUY
$1.53 - $3.45 $231 - $520
151 Added 0.62%
24,416 $37,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $38.6M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.